1Koch CC, Esteban DJ, Chin AC, et al. Apoptosis, oxidative metabolism and interleukin - 8 production in human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae. J Antimicrob Chemother, 2000, 46:19 - 26.
2Wenisch C, Parschalk B, Zedtwitz-Liebenstein K,et al. Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry. Antimicrob Agents Chemother, 1996, 40:2039 - 20
3Yamaryo T, Oishi K, Yoshimine H, et al. Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages. Antimicrob Agents Chemother, 2003,47:48 -53.
4Schultz MJ, Speelman P, Hack CE, et al. Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae. J Antimicrob Chemother, 2000, 46:235 - 240.
5Kurdowska A, Noble JM, Griffith DE. The effect of azithromycin and clarithromycin on ex vivo interleukin - 8 ( IL - 8 ) release from whole blood and IL- 8 production by human alveolar macrophages. J Antimicrob Chemother, 2001, 47: 867 - 870.
6Aoshiba K, Nagai A, Konno K. Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob Agents Chemother, 1995,39: 872 - 877.
7Komine M, Tamki K. An open trial of oral macrolide treatment for psoriasis vulgaris. J Dermatol, 2000, 27:508 - 512.
8Fox BJ, Odom RB, Findlay RF. Erythromycin therapy in bullous pemphigoid: possible anti-inflammatory effects. J Am Acad Dermatol,1982, 7:504-510.
9Akamatsu H, Tomita T, Horio T. Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes. Dermatology, 2002, 204:277 - 280.
10Yazawa N, Ihn H, Yamane K, et al. The successful treatment of prurigo pigmentosa with macrolide antibiotics. Dermatology, 2001, 202:67 - 69.
